Idexx Laboratories
IDXX
685 hedge funds and large institutions have $17.1B invested in Idexx Laboratories in 2019 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 246 increasing their positions, 223 reducing their positions, and 69 closing their positions.
29% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 69
19% more capital invested
Capital invested by funds: $14.4B → $17.1B (+$2.67B)
10% more repeat investments, than reductions
Existing positions increased: 246 | Existing positions reduced: 223
2% more funds holding
Funds holding: 671 → 685 (+14)
0.73% more ownership
Funds ownership: 88.15% → 88.88% (+0.73%)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
45% less call options, than puts
Call options by funds: $37.9M | Put options by funds: $69.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$161M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$101M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$76.4M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$59.7M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$44.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$101M |
| 2 |
Renaissance Technologies
New York
|
-$88.2M |
| 3 |
Jennison Associates
New York
|
-$72.2M |
| 4 |
Janus Henderson Group
London,
|
-$68.4M |
| 5 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$42.3M |
IDXX Hedge Fund Activity: Q1 2019 in Review
685 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2019, worth a combined $17.1B — up 19% from $14.4B a quarter earlier.
Buyers outnumbered sellers: 89 funds opened new IDXX positions and 69 closed out — a net gain of 20 holders — while 246 added to existing stakes and 223 trimmed.
The largest buyer was American Century Companies, adding an estimated $161M. The largest seller was Goldman Sachs, cutting an estimated $101M.
- 685 institutional investors held Idexx Laboratories (IDXX) as of Q1 2019, up from 671 in Q4 2018.
- Funds reported $17.1B of Idexx Laboratories stock for Q1 2019, up 19% quarter-over-quarter.
- 89 funds opened new Idexx Laboratories positions in Q1 2019 and 69 closed out, a net change of +20 holders.
- The largest Idexx Laboratories buyer in Q1 2019 was American Century Companies, an estimated $161M added.
- The largest Idexx Laboratories seller in Q1 2019 was Goldman Sachs, an estimated $101M sold.
Based on aggregated 13F filings for Q1 2019.